Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Changes Name to Icoria

NEW YORK, Aug. 17 (GenomeWeb News) - Paradigm Genetics announced today that it has changed its name to Icoria effective immediately, and has correspondingly changed its Nasdaq ticker from PDGM to ICOR.

 

The Research Triangle Park, NC company said the name change is meant to communicate underlying changes in focus from genomics to systems biology, and the increased emphasis on healthcare, especially after the acquisition of TissueInformatics in March.

 

"This represents the culmination of a process of strategic change from a functional genomics company serving the agrichemical sector to a systems biology company conducting cutting-edge, product-focused discovery and development research in both healthcare and agriculture. Icoria is a systems biology leader, unique in both the breadth of its core technology platforms and its ability to commercialize those technologies," Steven Burrill, Chairman of the Board of Icoria, said in a statement.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.